Buy Seroflo Inhaler

Seroflo Inhaler

What Is Seroflo Inhaler?

Seroflo Inhaler is a prescription-only medication used to manage chronic respiratory conditions. It contains two active ingredients-fluticasone propionate, an inhaled corticosteroid (ICS), and salmeterol xinafoate, a long-acting β₂-agonist (LABA). The inhaler delivers these drugs in fixed combination strengths of 25 µg fluticasone / 125 µg salmeterol or 25 µg fluticasone / 250 µg salmeterol per actuation. In Hong Kong, Seroflo is regulated by the Department of Health and is classified as a prescription (Rx) product.

How Seroflo Inhaler Works in the Body

• Fluticasone reduces airway inflammation by binding to glucocorticoid receptors in lung tissue, which suppresses the release of inflammatory mediators such as cytokines and prostaglandins. This effect helps to decrease swelling, mucus production, and airway hyper-responsiveness.
• Salmeterol stimulates β₂-adrenergic receptors on the smooth muscle lining the bronchi. Activation of these receptors relaxes the muscle, leading to bronchodilation that persists for up to 12 hours.
• The combined action provides both anti-inflammatory and bronchodilatory benefits, improving airflow, reducing symptom flare-ups, and enhancing overall lung function.
• Onset of bronchodilation typically occurs within 15-30 minutes, with peak anti-inflammatory effects developing over several days of regular use. Systemic absorption of fluticasone is minimal, limiting systemic side-effects when the inhaler is used as directed.

Conditions Treated by Seroflo Inhaler

Seroflo is approved for the maintenance treatment of asthma and for the prevention of COPD (chronic obstructive pulmonary disease) exacerbations in patients who require both an inhaled corticosteroid and a long-acting β₂-agonist. It is not intended for acute symptom relief; patients should have a rapid-acting bronchodilator (e.g., salbutamol) on hand for rescue use.

• Asthma: Adults and adolescents who remain symptomatic despite low-dose inhaled corticosteroid therapy.
• COPD: Patients with a history of exacerbations who need additional bronchodilation and anti-inflammatory control.

The medication is typically prescribed when a clinician determines that a combination approach will improve control and reduce the frequency of flare-ups.

Patient Suitability and Contraindications

Who Should Use Seroflo?

• Adults and adolescents (≥12 years) with a confirmed diagnosis of asthma or COPD who require both an ICS and a LABA for long-term control.
• Individuals who can reliably use a metered-dose inhaler (MDI) with a spacer if needed.

Absolute Contraindications

• Known hypersensitivity to fluticasone, salmeterol, or any excipients in the inhaler.
• A history of severe hypersensitivity reactions (e.g., anaphylaxis) to other inhaled corticosteroids or β₂-agonists.

Relative Contraindications & Precautions

• Pregnancy & lactation: Fluticasone is Category C; salmeterol is Category B. Use only if the expected benefit outweighs potential risk.
• Cardiovascular disease: Caution in patients with arrhythmias, coronary artery disease, or uncontrolled hypertension, as systemic β₂-agonist exposure can increase heart rate and blood pressure.
• Thyroid disorders: Monitor for signs of hyperthyroidism because β₂-agonists can exacerbate symptoms.
• Severe hepatic impairment: May increase systemic exposure to fluticasone; dose adjustments are not formally defined, so clinical judgment is required.
• Patients with a history of paradoxical bronchospasm after inhaled corticosteroid use should be closely observed.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Oral thrush (candidiasis): Frequently reported; reduces with rinsing the mouth after each use.
• Hoarseness or dysphonia: Often resolves with proper inhaler technique and mouth rinsing.
• Headache: Usually mild and transient.

Serious Adverse Events

• Paradoxical bronchospasm: Sudden worsening of breathing; requires immediate medical attention.
• Systemic corticosteroid effects: Rare but may include adrenal suppression, bone density loss, or cataracts with long-term high-dose use.
• Cardiovascular events: Palpitations, tachycardia, or arrhythmias can occur, especially in patients with existing heart disease.

Drug Interactions

• Beta-blockers (non-selective): May diminish salmeterol’s bronchodilator effect and precipitate bronchospasm.
• Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): Can increase systemic exposure to fluticasone, raising the risk of corticosteroid-related side effects.
• Other inhaled or systemic corticosteroids: Concurrent use may amplify systemic steroid effects; clinicians should monitor for signs of adrenal suppression.

Patients should provide a complete medication list-including over-the-counter drugs, supplements, and herbal products-to their healthcare provider before starting Seroflo.

Food and Lifestyle Interactions

• Food: No specific dietary restrictions; the inhaler can be used with or without meals.
• Alcohol: Moderate consumption does not directly affect drug efficacy but may exacerbate respiratory symptoms in some individuals.
• Driving: No impairment is expected at therapeutic doses, but patients experiencing dizziness or severe bronchospasm should avoid operating machinery.

How to Take Seroflo Inhaler

• Standard dosing: One inhalation (two actuations) twice daily, typically 12 hours apart (e.g., morning and evening). Each inhalation delivers either 25 µg fluticasone + 125 µg salmeterol or 25 µg fluticasone + 250 µg salmeterol, depending on the prescribed strength.
• Administration technique:
• Shake the inhaler well before each use.
• Exhale fully, place the mouthpiece between lips, and press the canister once while inhaling slowly and deeply.
• Hold breath for 10 seconds, then exhale slowly.
• If a spacer is prescribed, attach it and follow the same steps.
• Missed dose: If a dose is forgotten, take it as soon as remembered unless the next scheduled dose is within 4 hours; in that case, skip the missed dose and resume the regular schedule. Do not double the dose.
• Overdose: Symptoms may include severe throat irritation, wheezing, or signs of systemic corticosteroid exposure (e.g., swelling, hypertension). Seek emergency medical care; treatment is supportive.
• Discontinuation: The inhaler can be stopped without tapering, but abrupt cessation may result in loss of asthma or COPD control. A physician should guide any changes.

Monitoring and Follow-Up

• Lung function testing: Spirometry (FEV₁) should be performed before initiating therapy and periodically (e.g., every 3-6 months) to assess response.
• Oral health: Patients should be examined for signs of thrush or hoarseness at each follow-up visit.
• Growth monitoring (pediatric use, though not the primary target here): Long-term high-dose inhaled corticosteroids can affect growth velocity; periodic assessment is advised.
• Adverse event review: Any new or worsening cardiovascular symptoms, severe headaches, or visual changes warrant prompt evaluation.

Storage and Handling

• Keep the inhaler at room temperature (15-30 °C), away from direct sunlight, heat, and moisture.
• Store the canister upright to ensure consistent spray performance.
• Do not freeze; exposure to extreme cold can alter the propellant.
• Replace the inhaler after 12 months of opening or when the dose counter indicates the device is empty, even if there is remaining medication.
• Dispose of the canister according to local hazardous waste guidelines; many pharmacies in Hong Kong offer take-back programs.

Medication-Specific Glossary

Inhaled Corticosteroid (ICS)

A class of anti-inflammatory drugs delivered directly to the lungs to reduce airway swelling and mucus production with minimal systemic absorption.

Long-acting β₂-agonist (LABA)

A bronchodilator that activates β₂-adrenergic receptors, providing sustained airway relaxation for up to 12 hours.

FEV₁ (Forced Expiratory Volume in 1 second)

The volume of air expelled during the first second of a forced exhalation; a key measure of airway obstruction.

Paradoxical Bronchospasm

An unexpected constriction of the airways that can occur after inhaled medication use, requiring immediate medical attention.

Systemic Absorption

The process by which a drug enters the bloodstream and circulates throughout the body beyond its intended site of action.

Medical Disclaimer

This article provides educational information about Seroflo Inhaler and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.